Know Cancer

or
forgot password
  • cancer clinical trials in lenexa, KS

  • A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    Kansas City Cancer Centers
    Lenexa, Kansas
    Lymphoma, T-Cell, Peripheral
    An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    MidAmerica Neuroscience Institute
    Lenexa, Kansas
    Multiple Sclerosis, Relapsing-Remitting
    Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
    Kansas City Cancer Centers
    Lenexa, Kansas
    Palmar-Plantar Erythrodysesthesia, Breast Cancer
    Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization
    Teva Investigational Site 10565
    Lenexa, Kansas
    Cardiac Conduction and Repolarization
    Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel
    Kansas City Cancer Centers
    Lenexa, Kansas
    Hormone-Refractory Prostate Cancer
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    Kansas City Cancer Ctr. South
    Lenexa, Kansas 66214
    Non Small Cell Lung Carcinoma
    Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
    Kansas City Cancer Center - Central Research Dept. Data Office & Drug Discovery Location
    Lenexa, Kansas 66214
    Carcinoma, Non-Small-Cell Lung
    Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
    Mid America Neuroscience Institute, 8550 Marshall Drive, Suite 100
    Lenexa, Kansas 66214
    Multiple Sclerosis
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
    MidAmerica Neuroscience Institute
    Lenexa, Kansas
    Multiple Sclerosis, Relapsing-Remitting
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    MidAmerica Neuroscience Institute
    Lenexa, Kansas
    Multiple Sclerosis, Relapsing-Remitting
    Study to Evaluate Erlotinib With or Without SNDX-275 in the Treatment of Patients With Advanced NSCLC
    Kansas City Cancer Centers
    Lenexa, Kansas
    Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung
    Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
    Mid America Neuroscience Institute
    Lenexa, Kansas 66214
    Multiple Sclerosis